PUNCH CD3-OLS Study
Join the Battle to Defeat C. diff Infection
If you have been diagnosed C. diff, you are not alone. A research study at the Louisiana Research Center aims to stop C. diff from returning.
PUNCH CD3-OLS is a clinical study to evaluate the safety and tolerability of Rebiotix RBX2660 for the prevention of recurrent Clostridium difficile infection (C. diff or CDI). With this study option, many more people that suffer from recurrent C. diff may now qualify for study participation.